adverse event identification and management in locally advanced/metastatic urothelial carcinoma
Published 1 year ago • 68 plays • Length 39:24Download video MP4
Download video MP3
Similar videos
-
17:32
video series - urothelial carcinoma: management of ev adverse events - chapter 1: introduction to ev
-
32:58
video series - urothelial carcinoma: management of ev adverse events - chapter 2: skin reactions
-
30:33
advanced urothelial carcinoma: expert guidance to navigate an evolving therapeutic landscape
-
9:10
petros grivas, esmo 2019 - advances in metastatic urothelial cancer
-
31:01
video series - urothelial carcinoma: management of ev aes - chapter 4: hyperglycemia
-
4:55
immunotherapy: adverse events
-
20:38
recent advances in the management of urothelial carcinomas
-
56:17
live from aua2019: management of advanced and metastatic urothelial carcinoma
-
29:53
podcast series - urothelial carcinoma: management of enfortumab vedotin adverse events - ep4: hyp...
-
22:48
podcast series - urothelial carcinoma: management of enfortumab vedotin adverse events - ep3: per...
-
1:07
current diagnosis and management of immune related adverse events (iraes) induced by ... | rtcl.tv
-
30:32
immunotherapy of prostate cancer and urothelial cancer. future directions | winald gerritsen
-
1:12:06
learn all about urothelial cancer
-
4:38
emerging systemic therapies in rare urothelial cancer variants
-
1:46
adverse events for medical devices trailer
-
5:00
hematologic adverse events with adcs in breast cancer: optimal management strategies
-
9:40
industry perspective: the role of uro17 in the diagnosis and management of bladder cancer
-
17:04
an overview of clinical trials in urothelial carcinoma
-
36:42
showcase 4 : using discrete event simulation to identify the delays in a bladder cancer pathway